282 related articles for article (PubMed ID: 11195465)
21. Alteration of cell growth and morphology by overexpression of transforming growth factor beta type II receptor in human lung adenocarcinoma cells.
Kim TK; Mo EK; Yoo CG; Lee CT; Han SK; Shim YS; Kim YW
Lung Cancer; 2001; 31(2-3):181-91. PubMed ID: 11165397
[TBL] [Abstract][Full Text] [Related]
22. Lack of correlation between growth inhibition by TGF-beta and the percentage of cells expressing type II TGF-beta receptor in human non-small cell lung carcinoma cell lines.
López-González JS; Aguilar-Cázares D; Prado-García H; Nieto-Rodríguez A; Mandoki JJ; Avila-Moreno F; Rivera RM; Chavarría-Garcés J
Lung Cancer; 2002 Nov; 38(2):149-58. PubMed ID: 12399126
[TBL] [Abstract][Full Text] [Related]
23. The expression levels and the differential expression of transforming growth factor-beta receptors in dermatofibroma and dermatofibrosarcoma protuberans.
Kubo M; Ihn H; Yamane K; Tamaki K
Br J Dermatol; 2006 May; 154(5):919-25. PubMed ID: 16634896
[TBL] [Abstract][Full Text] [Related]
24. Differential regulation of protease and extracellular matrix protein expression by transforming growth factor-beta 1 in non-small cell lung cancer cells and normal human bronchial epithelial cells.
Jakowlew SB; Mariano JM; You L; Mathias A
Biochim Biophys Acta; 1997 Aug; 1353(2):157-70. PubMed ID: 9294010
[TBL] [Abstract][Full Text] [Related]
25. Distinct mechanisms of TGF-beta1-mediated epithelial-to-mesenchymal transition and metastasis during skin carcinogenesis.
Han G; Lu SL; Li AG; He W; Corless CL; Kulesz-Martin M; Wang XJ
J Clin Invest; 2005 Jul; 115(7):1714-23. PubMed ID: 15937546
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms of mitotic inhibition in corneal endothelium: contact inhibition and TGF-beta2.
Joyce NC; Harris DL; Mello DM
Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2152-9. PubMed ID: 12091410
[TBL] [Abstract][Full Text] [Related]
27. Transforming growth factor betas and their signaling receptors in human hepatocellular carcinoma.
Abou-Shady M; Baer HU; Friess H; Berberat P; Zimmermann A; Graber H; Gold LI; Korc M; Büchler MW
Am J Surg; 1999 Mar; 177(3):209-15. PubMed ID: 10219856
[TBL] [Abstract][Full Text] [Related]
28. Transforming growth factor-beta pathway in human renal cell carcinoma and surrounding normal-appearing renal parenchyma.
Cardillo MR; Lazzereschi D; Gandini O; Di Silverio F; Colletta G
Anal Quant Cytol Histol; 2001 Apr; 23(2):109-17. PubMed ID: 11332076
[TBL] [Abstract][Full Text] [Related]
29. Expression of transforming growth factor beta ligand and receptor messenger RNAs in lung cancer cell lines.
Jakowlew SB; Mathias A; Chung P; Moody TW
Cell Growth Differ; 1995 Apr; 6(4):465-76. PubMed ID: 7794814
[TBL] [Abstract][Full Text] [Related]
30. Genetic integrity of transforming growth factor beta (TGF-beta) receptors in cervical carcinoma cell lines: loss of growth sensitivity but conserved transcriptional response to TGF-beta.
Kang SH; Won K; Chung HW; Jong HS; Song YS; Kim SJ; Bang YJ; Kim NK
Int J Cancer; 1998 Aug; 77(4):620-5. PubMed ID: 9679767
[TBL] [Abstract][Full Text] [Related]
31. Contextual effects of transforming growth factor beta on the tumorigenicity of human colon carcinoma cells.
Ye SC; Foster JM; Li W; Liang J; Zborowska E; Venkateswarlu S; Gong J; Brattain MG; Willson JK
Cancer Res; 1999 Sep; 59(18):4725-31. PubMed ID: 10493532
[TBL] [Abstract][Full Text] [Related]
32. Transforming growth factor-beta (TGF-beta)-induced down-regulation of cyclin A expression requires a functional TGF-beta receptor complex. Characterization of chimeric and truncated type I and type II receptors.
Feng XH; Filvaroff EH; Derynck R
J Biol Chem; 1995 Oct; 270(41):24237-45. PubMed ID: 7592630
[TBL] [Abstract][Full Text] [Related]
33. Dysfunctional transforming growth factor-beta receptor II accelerates prostate tumorigenesis in the TRAMP mouse model.
Pu H; Collazo J; Jones E; Gayheart D; Sakamoto S; Vogt A; Mitchell B; Kyprianou N
Cancer Res; 2009 Sep; 69(18):7366-74. PubMed ID: 19738062
[TBL] [Abstract][Full Text] [Related]
34. Increased glomerular and tubular expression of transforming growth factor-beta1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse.
Hong SW; Isono M; Chen S; Iglesias-De La Cruz MC; Han DC; Ziyadeh FN
Am J Pathol; 2001 May; 158(5):1653-63. PubMed ID: 11337363
[TBL] [Abstract][Full Text] [Related]
35. Transfection of the type II TGF-beta receptor into colon cancer cells increases receptor expression, inhibits cell growth, and reduces the malignant phenotype.
MacKay SL; Auffenberg T; Tannahill CL; Ksontini R; Josephs MD; Nowak M; Moldawer LL; Copeland EM
Ann Surg; 1998 Jun; 227(6):781-9. PubMed ID: 9637541
[TBL] [Abstract][Full Text] [Related]
36. Detection of the transcripts and proteins for the transforming growth factor-beta isoforms and receptors in mouse lung tumorigenesis using in situ hybridization and immunohistochemistry in paraffin-embedded tissue sections.
Jakowlew SB; Mariano J
Methods Mol Med; 2003; 74():145-66. PubMed ID: 12415692
[No Abstract] [Full Text] [Related]
37. Cooperative binding of transforming growth factor (TGF)-beta 2 to the types I and II TGF-beta receptors.
Rodriguez C; Chen F; Weinberg RA; Lodish HF
J Biol Chem; 1995 Jul; 270(27):15919-22. PubMed ID: 7608141
[TBL] [Abstract][Full Text] [Related]
38. Tissue expression of transforming growth factor-beta1 and its receptors: correlation with pathologic features and biochemical progression in patients undergoing radical prostatectomy.
Shariat SF; Menesses-Diaz A; Kim IY; Muramoto M; Wheeler TM; Slawin KM
Urology; 2004 Jun; 63(6):1191-7. PubMed ID: 15183988
[TBL] [Abstract][Full Text] [Related]
39. Downregulation of transforming growth factor beta type II receptor in laryngeal carcinogenesis.
Franchi A; Gallo O; Sardi I; Santucci M
J Clin Pathol; 2001 Mar; 54(3):201-4. PubMed ID: 11253131
[TBL] [Abstract][Full Text] [Related]
40. Endocervical cancer is associated with an increase in the ligands and receptors for transforming growth factor-beta and a contrasting decrease in p27(Kip1).
Farley J; Gray K; Nycum L; Prentice M; Birrer MJ; Jakowlew SB
Gynecol Oncol; 2000 Aug; 78(2):113-22. PubMed ID: 10926789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
